June 10, 2020
From the beginning of the current global health pandemic caused by COVID-19, the Max Cure Foundation grew concerned about the impact to come on the childhood […]
- All
- Advocacy
- Blog
- Dunk Your Kicks
- Events
- Executive Director's Corner
- Fundraisers
- Impact Reports
- Junior Board of Directors
- MCF Team & Volunteers
- Media
- Our Supporters Stories
- Press
- Prevention Initiative
- Remembering Richard
- Research
- Research News
- Roar Beyond Barriers
- Roar Beyond Barriers Families
- September Honorees
- Trending Stories
- Uncategorized
June 27, 2018
Executive Director Jonathan Agin recently traveled to Seattle, Washington from June 12-14th to attend the annual meeting of the Coalition Against Childhood Cancer, also known as […]
January 31, 2018
Improving Childhood Cancer Survivorship by Monitoring and Detoxifying Metals In the early part of 2017 the Max Cure Foundation, as a result of a grant provided […]
January 8, 2018
The Max Cure Foundation’s Aggressive Research Mission and Continued Legacy of Support for Memorial Sloan Kettering Cancer Center Almost ten years ago, Max Plotkin sat anxiously […]
June 22, 2017
One of the three pillars of Max Cure’s mission is funding research. Since our beginning, when Max was diagnosed in 2007 and fighting for his life, […]
October 28, 2015
Progress in Action: Max Cure Foundation’s Contributions to the Immune Cell Laboratory at Memorial Sloan-Kettering Cancer Center As the first Executive Director of the Max Cure […]
April 8, 2015
In July, 2012, President Obama signed into law the Creating Hope Act for the purpose of incentivizing pharmaceutical companies, biotech firms and universities in seeking cures for what are known as Rare Children’s Diseases. Childhood Cancer is considered such a Rare Children’s Disease. Companies that are successful receiving approval from the FDA of drugs that meet the criteria of the Act receive vouchers that can be valuable to the companies in their efforts to bring other drugs to the market or, if they wish, can result in the sales of the vouchers by the companies to other companies at substantial prices. On March 10, 2015 a new drug specifically for children, aimed at high-risk neuroblastoma received FDA approval thanks to the Creating Hope Act.
December 29, 2014
The Max Cure Foundation's Vice-Chairman, Richard Plotkin, Shares our 2014 Year at a Glance. Together We Will Roar For a Cure Until One is Found!
August 5, 2014
A childhood cancer advocate and clinical pharmacist gives her informed plea for why Compassionate Use makes sense for Nathalie.